Ameloblastoma screening

Ameloblastoma Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Ameloblastoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
X-Ray
CT
MRI
Echocardiography and Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Ameloblastoma screening On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Ameloblastoma screening All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Ameloblastoma screening
CDC on Ameloblastoma screening
Ameloblastoma screening in the news
Blogs on Ameloblastoma screening
Directions to Hospitals Treating Ameloblastoma
Risk calculators and risk factors for Ameloblastoma screening

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: {{Simrat]]

Overview

According to the United States Preventive Services Task Force, screening for ameloblastoma is not recommended.

Screening

Current medical research has not established a way of preventing ameloblastoma. Regular medical screening at periodic intervals with scans and physical examinations are important.